Business|Economy|Europe|Health
Novartis could expand direct-to-patient sales in US, CEO says
Swiss drugmaker Novartis is exploring options to add more medicines to its direct-to-patient platform that is expected to launch in the U.S. on November 1, CEO Vas Narasimhan told Reuters in an interview on Tuesday."We're certainly looking to see if we can add other medicines to the platform," Narasimhan said, while cautioning that "no concrete plans" were yet confirmed.Pharmaceutical companies are scrambling to respond to U.S. President Donald Trump's pressure on the industry to slash drug prices and to cut out middlemen like pharmacies, insurers and pharmacy benefit managers.DRUGMAKERS LOOK
Stragglers from Myanmar scam center raided by army cross into Thailand as buildings are blown up
Why the Trump administration’s comparison of antifa to violent terrorist groups doesn’t track
Why you can salvage moldy cheese but never spoiled meat − a toxicologist advises on what to watch out for
‘Fawlty Towers’ actress Prunella Scales dies aged 93
Game recognize game: Other US sports stars are in awe of Shohei Ohtani
The Glozel affair: A sensational archaeological hoax made science front-page news in 1920s France